Unilever Attempt to Buy GlaxoSmithKline's Consumer Healthcare Business Falls Flat
Jason Moser, a senior analyst at the Motley Fool, breaks down Unilever's expansion into healthcare and outlines the challenges the company faces gaining market share in this field.
Wealthfront’s CFO Alan Iberman talks the $2.05B IPO and the major moment for robo banking as the company bets on AI, automation, and “self-driving money."